Đang chuẩn bị liên kết để tải về tài liệu:
Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

To explore the potential pathogenesis and clinical features of second primary glioblastoma (spGBM) follow‑ ing first primary renal cell carcinoma (fpRCC). Patients with spGBM after fpRCC were enrolled from our institution and the SEER dataset. Sanger sequencing, whole genome sequencing, and immunohistochemistry were used to detect molecular biomarkers. |

TÀI LIỆU LIÊN QUAN

Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma

Diffusion and Use of Genomic Innovations in Health and Medicine: Workshop Summary

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

Classification based on extensions of LS-PLS using logistic regression: Application to clinical and multiple genomic data

The emerging clinical relevance of genomic profiling in neuroendocrine tumours

Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma

Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer

Genome comparison between clinical and environmental strains of Herbaspirillum seropedicae reveals a potential new emerging bacterium adapted to human hosts

IMNI PRECISION trial protocol: A phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer

Báo cáo y học: "Characterization and modeling of the Haemophilus influenzae core and supragenomes based on the complete genomic sequences of Rd and 12 clinical nontypeable strain"